home.social

#targetedproteindegradation — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #targetedproteindegradation, aggregated by home.social.

fetched live
  1. SK Biopharmaceuticals Hires Global Experts to Boost Neuroscience, Oncology R&D

    Kim Tae-ho, head of the Neuroscience Division at SK BiopharmaceuticalsKim Su-young, MD, SK Biopharmaceuticals SK Biopharmaceuticals (326030) is…
    #EuropeSays #Korea #KR #SK #carisbamate #clinicaldevelopment #neuroscienceR&D #radiopharmaceuticaltherapy #SKBiopharmaceuticals #SKGroup #SKLifeScience #targetedproteindegradation
    europesays.com/korea/146741/

  2. Last paper post of the year!

    Amazing Nature Chemical Biology paper by the group of Christina Woo. PCMT1 installs cyclic imides on asparagines at the C-terminus of proteins via SAM-dependent methyl ester formation, which then leads to degradation using cereblon.

    nature.com/articles/s41589-025
    #Chemistry #ChemBio #TPD #TargetedProteinDegradation #Degraders

  3. Last paper post of the year!

    Amazing Nature Chemical Biology paper by the group of Christina Woo. PCMT1 installs cyclic imides on asparagines at the C-terminus of proteins via SAM-dependent methyl ester formation, which then leads to degradation using cereblon.

    nature.com/articles/s41589-025
    #Chemistry #ChemBio #TPD #TargetedProteinDegradation #Degraders

  4. Last paper post of the year!

    Amazing Nature Chemical Biology paper by the group of Christina Woo. PCMT1 installs cyclic imides on asparagines at the C-terminus of proteins via SAM-dependent methyl ester formation, which then leads to degradation using cereblon.

    nature.com/articles/s41589-025
    #Chemistry #ChemBio #TPD #TargetedProteinDegradation #Degraders

  5. Last paper post of the year!

    Amazing Nature Chemical Biology paper by the group of Christina Woo. PCMT1 installs cyclic imides on asparagines at the C-terminus of proteins via SAM-dependent methyl ester formation, which then leads to degradation using cereblon.

    nature.com/articles/s41589-025
    #Chemistry #ChemBio #TPD #TargetedProteinDegradation #Degraders

  6. 🤖 Can AI help us predict and prevent off-target effects in PROTAC drug design?

    🔗 Predicting PROTAC off-target effects via warhead involvement levels in drug–target interactions using graph attention neural networks. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2025.10

    📚 CSBJ: csbj.org/

    #DrugDevelopment #StructuralBiology #ChemicalBiology #PROTAC #DrugDiscovery #Cheminformatics #Bioinformatics #PrecisionMedicine #TargetedProteinDegradation

  7. 🤖 Can AI help us predict and prevent off-target effects in PROTAC drug design?

    🔗 Predicting PROTAC off-target effects via warhead involvement levels in drug–target interactions using graph attention neural networks. Computational and Structural Biotechnology Journal, DOI: doi.org/10.1016/j.csbj.2025.10

    📚 CSBJ: csbj.org/

    #DrugDevelopment #StructuralBiology #ChemicalBiology #PROTAC #DrugDiscovery #Cheminformatics #Bioinformatics #PrecisionMedicine #TargetedProteinDegradation

  8. Now online at @Nature Reviews Clinical Oncology from my Arvinas colleague Debbie Chirnomas, myself, and Craig @crews: Protein degraders enter the clinic -- a new approach to cancer therapy. Check it out! #TargetedProteinDegradation #TPD #PROTAC
    nature.com/articles/s41571-023

  9. Now online at @Nature Reviews Clinical Oncology from my Arvinas colleague Debbie Chirnomas, myself, and Craig @crews: Protein degraders enter the clinic -- a new approach to cancer therapy. Check it out! #TargetedProteinDegradation #TPD #PROTAC
    nature.com/articles/s41571-023

  10. Now online at @Nature Reviews Clinical Oncology from my Arvinas colleague Debbie Chirnomas, myself, and Craig @crews: Protein degraders enter the clinic -- a new approach to cancer therapy. Check it out! #TargetedProteinDegradation #TPD #PROTAC
    nature.com/articles/s41571-023

  11. Now online at @Nature Reviews Clinical Oncology from my Arvinas colleague Debbie Chirnomas, myself, and Craig @crews: Protein degraders enter the clinic -- a new approach to cancer therapy. Check it out! #TargetedProteinDegradation #TPD #PROTAC
    nature.com/articles/s41571-023

  12. The mystery of @genentech's monovalent BRD degraders equipped with a propargyl "degradation tail" has been solved by researchers @abbvie: a #CRISPR screen reveals molecular glue-like recruitment of #DCAF16.
    #TargetedProteinDegradation #MonovalentDegraders
    pubs.acs.org/doi/full/10.1021/

  13. The mystery of @genentech's monovalent BRD degraders equipped with a propargyl "degradation tail" has been solved by researchers @abbvie: a #CRISPR screen reveals molecular glue-like recruitment of #DCAF16.
    #TargetedProteinDegradation #MonovalentDegraders
    pubs.acs.org/doi/full/10.1021/

  14. The mystery of @genentech's monovalent BRD degraders equipped with a propargyl "degradation tail" has been solved by researchers @abbvie: a #CRISPR screen reveals molecular glue-like recruitment of #DCAF16.
    #TargetedProteinDegradation #MonovalentDegraders
    pubs.acs.org/doi/full/10.1021/

  15. The mystery of @genentech's monovalent BRD degraders equipped with a propargyl "degradation tail" has been solved by researchers @abbvie: a #CRISPR screen reveals molecular glue-like recruitment of #DCAF16.
    #TargetedProteinDegradation #MonovalentDegraders
    pubs.acs.org/doi/full/10.1021/

  16. nature.com/articles/s41589-022
    Nice addition to the #targetedproteindegradation literature but I wouldn't describe it as "a new strategy of targeted protein degradation through direct substrate recruitment to the 26S proteasome" since Janse and Church first described this approach in 2004. pubmed.ncbi.nlm.nih.gov/150394 #PROTACs

  17. nature.com/articles/s41589-022
    Nice addition to the #targetedproteindegradation literature but I wouldn't describe it as "a new strategy of targeted protein degradation through direct substrate recruitment to the 26S proteasome" since Janse and Church first described this approach in 2004. pubmed.ncbi.nlm.nih.gov/150394 #PROTACs

  18. nature.com/articles/s41589-022
    Nice addition to the #targetedproteindegradation literature but I wouldn't describe it as "a new strategy of targeted protein degradation through direct substrate recruitment to the 26S proteasome" since Janse and Church first described this approach in 2004. pubmed.ncbi.nlm.nih.gov/150394 #PROTACs

  19. nature.com/articles/s41589-022
    Nice addition to the #targetedproteindegradation literature but I wouldn't describe it as "a new strategy of targeted protein degradation through direct substrate recruitment to the 26S proteasome" since Janse and Church first described this approach in 2004. pubmed.ncbi.nlm.nih.gov/150394 #PROTACs

  20. nature.com/articles/s41589-022
    Nice addition to the #targetedproteindegradation literature but I wouldn't describe it as "a new strategy of targeted protein degradation through direct substrate recruitment to the 26S proteasome" since Janse and Church first described this approach in 2004. pubmed.ncbi.nlm.nih.gov/150394 #PROTACs

  21. An exciting new paper by researchers at Genentech led by Erin Dueber describes a ligase-agnostic #TargetedProteinDegradation platform based on direct 26S proteasome recruitment with macrocyclic PSMD2 ligands! Clever use of the D-enantiomeric macrocycle as an inactive control. These bifunctional ligands deliver target proteins to the 26S proteasome near the AAA+ unfoldase pore, bypassing the requirement for E3 ligase-mediated target ubiquitination prior to degradation!
    nature.com/articles/s41589-022

  22. An exciting new paper by researchers at Genentech led by Erin Dueber describes a ligase-agnostic #TargetedProteinDegradation platform based on direct 26S proteasome recruitment with macrocyclic PSMD2 ligands! Clever use of the D-enantiomeric macrocycle as an inactive control. These bifunctional ligands deliver target proteins to the 26S proteasome near the AAA+ unfoldase pore, bypassing the requirement for E3 ligase-mediated target ubiquitination prior to degradation!
    nature.com/articles/s41589-022

  23. An exciting new paper by researchers at Genentech led by Erin Dueber describes a ligase-agnostic #TargetedProteinDegradation platform based on direct 26S proteasome recruitment with macrocyclic PSMD2 ligands! Clever use of the D-enantiomeric macrocycle as an inactive control. These bifunctional ligands deliver target proteins to the 26S proteasome near the AAA+ unfoldase pore, bypassing the requirement for E3 ligase-mediated target ubiquitination prior to degradation!
    nature.com/articles/s41589-022

  24. An exciting new paper by researchers at Genentech led by Erin Dueber describes a ligase-agnostic #TargetedProteinDegradation platform based on direct 26S proteasome recruitment with macrocyclic PSMD2 ligands! Clever use of the D-enantiomeric macrocycle as an inactive control. These bifunctional ligands deliver target proteins to the 26S proteasome near the AAA+ unfoldase pore, bypassing the requirement for E3 ligase-mediated target ubiquitination prior to degradation!
    nature.com/articles/s41589-022